Autres langues Mithra Pharmaceuticals S.A.

Actions

Marché Fermé - Euronext Bruxelles Autres places de cotation 17:36:14 19/04/2024			Varia. 5j.	Varia. 1 janv.
0,224 ^EUR	-3,86 %		-0,88 %	-82,14 %

08/03	Mithra Pharmaceuticals SA publie ses résultats pour l'exercice clos le 31 décembre 2023	CI
05/03	Mithra Pharmaceuticals va lancer un processus de monétisation impliquant la vente d'actifs et d'activités	MT

Early data from Mithra's ESTELLE pediatric study to be presented at two upcoming congresses	17/04
Mithra bereikt mijlpaal in onderzoek naar estetrol	09/04
Mithra Pharmaceuticals S A : reaches milestone in estetrol skin study	08/04
Noodlijdend Mithra stelt jaarverslag uit	28/03
KBC Securities verlaagt koersdoel Mithra fors	08/03
Licht hogere start Brussel voorzien in aanloop naar banenrapport VS	08/03
Lagere omzet Mithra ondanks hogere productomzet	08/03
Mithra reports full year 2023 financial results	08/03
Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Mithra announces changes to its executive management	06/03
Mithra Pharmaceuticals to Initiate Monetization Process Involving Sale of Assets, Business	05/03
Mithra Pharmaceuticals Terminates CEO; Names CFO, COO as Successors	05/03
Mithra zet zichzelf in de etalage	05/03
Mithra announces changes to its executive management	05/03
Mithra announces changes to its executive management	05/03
Mithra initiates monetization process, receives bridge loan from existing lenders	05/03
Mithra Pharmaceuticals SA Announces CEO Changes	05/03
Mithra - DONESTA safety study for menopause completes treatment phase and advances to data management and reporting phase	29/02
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase	29/02
Mithra gaat volgende fase in met studie Donesta	28/02

Aucun résultat pour cette recherche